Profile data is unavailable for this security.
About the company
Jinyao Pharmaceutical Co Ltd, formerly Tianjin Tianyao Pharmaceuticals Co., Ltd., is a China-based company mainly engaged in the research and development, production and sales of corticosteroids and amino acid APIs and preparations. The Company's main products include dexamethasone series, prednisone series, methylprednisolone series, betamethasone series and more than 40 varieties of corticosteroid raw materials, 23 varieties of amino acid raw materials, and 16 dosage forms such as tablets, injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, and inhalation preparations. The Company mainly operates in the domestic market and overseas markets.
- Revenue in CNY (TTM)3.66bn
- Net income in CNY107.59m
- Incorporated1999
- Employees2.68k
- LocationJinyao Pharmaceutical Co LtdNo. 221, Huanghai Road, Development ZoneTIANJIN 300457ChinaCHN
- Phone+86 2 260740048
- Fax+86 2 265277561
- Websitehttp://www.tjpcty.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sinotherapeutics Inc | 368.86m | 76.25m | 4.13bn | 260.00 | 54.11 | 3.44 | -- | 11.18 | 0.1682 | 0.1682 | 0.8137 | 2.65 | 0.275 | 3.08 | 5.83 | 1,418,710.00 | 5.69 | -- | 6.09 | -- | 51.77 | -- | 20.67 | -- | 9.09 | -- | 0.00006 | -- | 21.13 | -- | -34.29 | -- | -- | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 400.25m | -314.32m | 4.21bn | 684.00 | -- | 1.22 | -- | 10.52 | -5.36 | -5.36 | 6.83 | 58.77 | 0.0915 | 0.8592 | 1.57 | 585,153.50 | -7.19 | 25.41 | -8.36 | 31.26 | 63.20 | 63.37 | -78.53 | 32.86 | 6.05 | -- | 0.086 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| Jinyao Pharmaceutical Co Ltd | 3.66bn | 107.59m | 4.32bn | 2.68k | 40.13 | 1.43 | -- | 1.18 | 0.0984 | 0.0984 | 3.35 | 2.76 | 0.5738 | 2.28 | 9.37 | 1,365,219.00 | 2.33 | 1.91 | 4.17 | 3.40 | 42.61 | 46.33 | 4.06 | 3.31 | 0.7584 | 27.18 | 0.2064 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
| Shanghai OPM Biosciences Co Ltd | 254.91m | 49.43m | 4.33bn | 285.00 | 87.82 | 2.01 | -- | 16.98 | 0.4294 | 0.4294 | 2.22 | 18.80 | 0.1095 | 2.07 | 2.54 | 894,431.90 | 2.09 | 4.34 | 2.16 | 4.65 | 58.86 | 58.31 | 19.06 | 23.40 | 19.91 | -- | 0.0315 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
| Assure Tech Hangzhou Co Ltd | 511.29m | 160.91m | 4.39bn | 791.00 | 27.31 | 0.8485 | -- | 8.60 | 1.27 | 1.27 | 4.02 | 40.75 | 0.0799 | 1.52 | 2.67 | 646,379.60 | 2.51 | 31.83 | 2.94 | 38.97 | 38.56 | 65.82 | 31.47 | 47.86 | 8.26 | -- | 0.0166 | 16.05 | -91.84 | 25.18 | -95.35 | 33.51 | 78.77 | -- |
| Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.41bn | 4.14k | 22.26 | 1.51 | -- | 1.53 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Shanghai Medicilon Inc | 1.17bn | -172.33m | 4.44bn | 2.60k | -- | 1.80 | -- | 3.78 | -1.24 | -1.24 | 9.11 | 18.34 | 0.4205 | 6.63 | 1.64 | 451,437.20 | -6.17 | 9.34 | -7.97 | 11.73 | 12.48 | 36.71 | -14.68 | 14.93 | 2.63 | -- | 0.1229 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.81bn | 94.97m | 4.46bn | 2.47k | 46.93 | 3.88 | -- | 2.46 | 0.2374 | 0.2374 | 4.52 | 2.87 | 0.6721 | 2.88 | 3.81 | 732,708.90 | 3.80 | 5.81 | 6.29 | 9.78 | 50.33 | 58.01 | 5.66 | 7.03 | 0.8245 | 7.04 | 0.5246 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
Data as of May 31 2024. Currency figures normalised to Jinyao Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 6.20m | 0.57% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 3.74m | 0.34% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 2.64m | 0.24% |
| The Vanguard Group, Inc.as of 30 Apr 2024 | 2.08m | 0.19% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 31 Dec 2023 | 1.49m | 0.14% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 31 Dec 2023 | 1.36m | 0.12% |
| Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 725.70k | 0.07% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 688.40k | 0.06% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 512.80k | 0.05% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 391.10k | 0.04% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
